Assure COVID-19 IgG/IgM rapid test

Assure COVID-19 IgG/IgM Rapid Test

Are you having symptoms similar to COVID-19 but are unsure that it might be influenza? If so, it is most reasonable to have a rapid test and be certain of your symptoms.

In that case, the Assure COVID-19 IgG/IgM rapid test could answer your suspicion. Assure COVID-19 IgG/IgM rapid test is a remarkably efficient antibody test to see whether someone has had the COVID-19 virus or not in a matter of minutes.

The test checks for the presence of antibodies in a person’s blood, which are proteins that the body makes to fight off foreign entities or viruses. And it can be done using blood taken from a vein, a finger prick, or liquid from the blood as serum and plasma.

Moreover, the Assure COVID-19 IgG/IgM rapid test is a POC (point-of-care) examination since only a healthcare professional can extract blood from a person. Also, the blood specimen needs to be collected in a specific way, using a substance called Sodium EDTA.

Besides that, several other POC and OTC rapid tests are relatively as effective and rapid as the Assure COVID-19 IgG/IgM rapid test. For example, the Accula SARS-CoV-2 test, Sienna and Salocor COVID-19 POC antigen test, Genabio and Flowflex antigen rapid test, BinaxNOW COVID-19 Ag card test, etc. are some of the highly demanded COVID rapid test kits.

Moving along, let us discuss additional information about the Assure COVID-19 IgG/IgM rapid test availability, accuracy, advantages, and instructions on how to use it.

What is COVID-19 IgG/IgM Rapid Test?

COVID-19 IgG/IgM rapid test is a lateral flow immunochromatographic assay for the detection of SARS-Cov-2 antibodies present in a patient’s blood taken from veins, fingertips, or blood plasma.

But what exactly is the COVID-19 IgG/IgM rapid test, and how does it work? Let us explain to you in simpler words.

As the name suggests, the COVID IgG/IgM rapid test checks for two types of antibodies in the blood specimen: IgG and IgM, using a substance called Sodium EDTA.

IgG antibodies are typically produced later in the course of an infection or developed due to vaccination against a certain foreign disease. Therefore, it indicates that the person has been infected in the past or has started producing antibodies because of the vaccine. IgG antibodies remain in the blood for a longer period of time and defend the body from further infection.

Meanwhile, IgM antibodies are the first antibodies produced earlier in response to the infection and typically go away over time, indicating a current or recent infection. If the IgM levels are low then it suggests that the infection has been present for a longer time.

In ordinary terms, the COVID-19 IgG/IgM Rapid Test is a quick way to see if someone has had COVID-19 in the past or if they currently possess the virus. The results are admiringly precise and generally available within a few minutes.

Assure COVID-19 IgG/IgM Rapid Test Availability

The Assure COVID-19 IgG/IgM rapid test is widely available worldwide. But it can only be purchased by a healthcare professional or pharmacist due to its exclusive nature and requirement for proper medical training.

Nonetheless, those living in rural areas can buy the test kit and use it under the observation of a trained health service assistant.

Moreover, we provide various test kits like the Assure COVID-19 IgG/IgM test and masks and PPE kits at a reasonable cost.

A global distributor, SVI Medical Group, offers test kits, PPE, masks, and other health equipment at a fair price.

Orders can be placed for any piece of equipment through a contact form, and a sales representative will follow up after you have provided your contact information.

Is the COVID-19 IgG/IgM Rapid Test Accurate?

The precision of antibody tests in identifying COVID-19 may vary depending on whether patients are asymptomatic or have mild or moderate symptoms.

When compared with several clinical studies, the Assure COVID-19 IgG/IgM tests targeted IgG or IgM antibodies most precisely. The tests identified 93% of COVID-19 cases when used to test individuals 21 days after experiencing initial symptoms. However, they also produced false positive results for 1% of people who did not have COVID-19.

Therefore, you should consult a physician or take a proper PCR test if you still have symptoms after taking the Assure COVID-19 IgG/IgM rapid test, and after COVID medication.

Specification of the Test Kit

In difference to the other test kits that use nasal or throat swab, the Assure COVID-19 IgG/IgM rapid test kit utilizes blood specimen from the veins or fingertip, or use serum or plasma from the blood.

It then finds out the antibodies present in the blood specimen to identify IgG or IgM antibodies and displays the result accordingly.

The test device initially provides different reagents and materials. You will be provided individually packed test devices, Buffer, disposable Pipettes, Alcohol Prep pad, package insert, and sterile safety lancet.

Some of the materials required for the test but unprovided in the testing device are a timer or stopwatch and a specimen collection container. You will have to manage these tools by yourself.

Why Should You Choose COVID-19 IgG/IgM Rapid Test?

The Assure COVID-19 IgG/IgM rapid test is a POC test which signifies it is better than most at-home tests. Plus, the test includes enhanced technology and gives faster outcomes.

Additional points on choosing the COVID-19 IgG/IgM rapid test are briefly mentioned below.

Handy-to-use: Assure COVID-19 IgG/IgM rapid test is a user-friendly test that can be easily performed in most locations without requiring laboratory facilities. This makes it ideal for use at home, as well as in large testing facilities.

Cost-effective: POC tests are typically designed to reach a wide audience, and as such, the Assure COVID-19 IgG/IgM rapid test is obtainable at an affordable price and accessible globally.

Accessibility: Moreover, the Assure COVID-19 IgG/IgM rapid test is approved by the FDA and recognized by other medical regulatory agencies worldwide, making it readily available and easily obtainable by licensed healthcare providers in various trial locations.

Quick Outcomes: Compared to home tests and laboratory tests, POC tests such as the Assure COVID-19 IgG/IgM test are faster and more precise. It provides results in 10 to 40 minutes without the need for lengthy processing times.

High Accuracy: Since this test checks specific antibodies in the blood specimen, it produces widely authentic results. Also, a medical specialist administers the trial in person which minimizes the risk of getting false positive results.

Instructions to Use Assure COVID-19 IgG/IgM Rapid Test

The IgG/IgM tests are conducted in authorized testing facilities. Also, only trained personnel and medical experts are allowed to take trials for COVID infection using the Assure COVID-19 IgG/IgM rapid test.

However, a person under the monitoring of a clinical specialist can follow the procedure from the instruction book and take the test.

Hence, restate the instructions that you need to follow in order to complete the Assure COVID-19 IgG/IgM rapid test successfully.

NOTE: Before applying the examination, allow the test device, specimen, buffer, and controls to reach room temperature (15-30 degree Celsius).

STEP 1:  First of all, wash your hands and clean the puncture finger with the Alcohol Prep Pad from the test kit.

STEP 2: Now, carefully remove the cap from the Safety Lancet. Push the Safety Lancet firmly against the puncture finger until it pricks the finger.

STEP 3: Use the Disposable Pipette to draw the blood specimen from your fingertip until the fill line of the Pipette is filled.

STEP 4: Then, transfer one drop of the specimen into the Specimen Well of the test device, add two drops of Buffer, and start the timer.

NOTE: Adding more or fewer drops of the specimen may lead to incorrect results. Likewise, do not add 1 drop or more than 2 drops of Buffer too.

STEP 5: Lastly, wait for the blue line to change to the red line and read the results after 15 minutes.

NOTE: Do not read the results earlier than 15 minutes or after 30 minutes have passed.

How to Interpret Conclusions?

Read the colors carefully and determine the results. Here are the ways to study the result from the Assure COVID-19 IgG/IgM rapid test.

IgM & IgG Positive: You will see two colored lines in IgG and IgM regions with a colored line in the Control Region (C). Moreover, the color intensity of the lines does not have to match, the result is positive if colored lines appear.

IgG Positive: The colored line in the Control Region (C) changes from blue to red as well as a colored line appears in the IgG test region. This means you may have been infected sometime in the past and might not have a current infection.

IgM Positive: With the appearance of a colored line in the IgM test region, the blue line in the Control Region changes from blue to red. This means you are currently infected with COVID-19.

Negative: The colored line in the Control Region changes from blue to red but no other colored line appears in the IgG or IgM regions.

Invalid: Control Line (C) fails to change color partially or completely from blue to red meanwhile other colored lines may or may not appear.

Furthermore, the color intensity in the test region may vary depending on the concentration of analytes present in the specimen. Hence, any shade of color appearing in the test regions should be considered positive.

Also, insufficient specimen volume, incorrect operating procedures, or expired tests generally lead to false or invalid results. In such cases, repeat the administration with a new kit and carefully follow the methods.

FAQs

What does IgM positive in rapid test means?

IgM generally implies the first antibody produced by the body’s immune system to defend itself from the virus. A positive IgM test means you may have been recently infected with COVID-19 or vaccinated against COVID.

Does IgG positive mean COVID?

Generally no. The presence of IgG antibodies in the blood indicates that in the recent past, you may have had a COVID-19 infection and have developed antibodies to fight against COVID in the future.